Skip to main content
Trending storyHistorical stories

Switchpoint Bio raises $5.3M pre-seed, emerges from stealth

1 reports1 report sources6 days agoUpdate

Get up to speed on this story

AI Summary

Switchpoint Bio, a biotech startup based in Helsinki and Cambridge, has emerged from stealth with $5.3 million in pre-seed funding. The round includes a $5 million investment from Treehouse Delmar Investments. The company says its technology measures drug-response biology from blood samples.

AI-generated from reports · 6 days agoUpdate

Report timeline

Follow the reports to understand different sides of the story.

Nov 11
  1. Tech.eu
    Switchpoint Bio Raises $5.3M Pre-Seed to Measure Drug Response Biology from Blood

    Helsinki-Cambridge biotech Switchpoint Bio has emerged from stealth with $5.3M in pre-seed funding.

Trend for this story

Comparable range current
3
Comparable range peak
10Nov 11 19:00
Change in the last 24 hours
-49%

Trends only compare the same entities observed consistently and completely, so the scope may be smaller than the current trending statistics. Move the pointer or click the chart to view hourly trending; use the left and right arrow keys on a keyboard to switch.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing